News Column

New Stem Cells Findings from L.T. Alvarim et al Outlined (Therapeutics with SPION-labeled stem cells for the main diseases related to brain aging: a...

September 8, 2014



New Stem Cells Findings from L.T. Alvarim et al Outlined (Therapeutics with SPION-labeled stem cells for the main diseases related to brain aging: a systematic review)

By a News Reporter-Staff News Editor at Clinical Trials Week -- New research on Stem Cell Research is the subject of a report. According to news reporting originating in Sao Paulo, Brazil, by NewsRx journalists, research stated, "The increase in clinical trials assessing the efficacy of cell therapy for structural and functional regeneration of the nervous system in diseases related to the aging brain is well known."

The news reporters obtained a quote from the research, "However, the results are inconclusive as to the best cell type to be used or the best methodology for the homing of these stem cells. This systematic review analyzed published data on SPION (superparamagnetic iron oxide nanoparticle)-labeled stem cells as a therapy for brain diseases, such as ischemic stroke, Parkinson's disease, amyotrophic lateral sclerosis, and dementia."

According to the news reporters, the research concluded: "This review highlights the therapeutic role of stem cells in reversing the aging process and the pathophysiology of brain aging, as well as emphasizing nanotechnology as an important tool to monitor stem cell migration in affected regions of the brain."

For more information on this research see: Therapeutics with SPION-labeled stem cells for the main diseases related to brain aging: a systematic review. International Journal of Nanomedicine, 2014;9():3749-3770. International Journal of Nanomedicine can be contacted at: Dove Medical Press Ltd, PO Box 300-008, Albany, Auckland 0752, New Zealand (see also Stem Cell Research).

Our news correspondents report that additional information may be obtained by contacting L.T. Alvarim, Nucleo Apoio Pesquisa Neurociencias Aplicadas, Sao Paulo, Brazil. Additional authors for this research include L.P. Nucci, J.B. Mamani, L.C. Marti, M.F. Aguiar, H.R. Silva, G.S. Silva, M.P. Nucci-da-Silva, E.A. DelBel and L.F. Gamarra.

Keywords for this news article include: Sao Paulo, Brazil, South America, Stem Cell Research

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Clinical Trials Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters